Nephros (NEPH) Total Liabilities (2010 - 2026)

Nephros has reported Total Liabilities for 17 years, with the latest figure at $3.8 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 43.8% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 43.8% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 31.01% from the prior year.
• Total Liabilities was $3.8 million for Q2 2026 at Nephros, up from $3.1 million in the prior quarter.
• The five-year high for Total Liabilities was $3.8 million in Q2 2026, with the low at $1.7 million in Q2 2023.
• Average Total Liabilities over 5 years is $2.7 million, with a median of $2.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities declined 29.98% in 2023, then surged 83.36% in 2024.
• Over 5 years, Total Liabilities stood at $2.1 million in 2022, then surged by 65.39% to $3.5 million in 2023, then dropped by 25.06% to $2.6 million in 2024, then surged by 31.01% to $3.4 million in 2025, then grew by 10.56% to $3.8 million in 2026.
• The last three Total Liabilities figures came in at $3.8 million (Q2 2026), $3.1 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.